Brooke M Emerling

Sanford Burnham Prebys Medical Discovery Institute

$5,524,939

Attributed

$5,524,939

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.2M · FY2020–25

$2M$1.5M$1M$500K$0

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$5,524,939 · 5

By mechanism

R01$4,446,740 · 2

P30$1,028,849 · 2

R13$49,350 · 1

Top collaborators

No co-investigators on record.

Most similar at Sanford Burnham Prebys Medical Discovery Institute

Same institution · by research overlap

Rolf Bodmer$26,992,998
Andrei L Osterman$14,236,902
Jamey Marth$29,024,297
Maximiliano A Dangelo$6,800,593
Robert C Rickert$772,056

Others in their field

Other Emerging Leaders on “Malignant Neoplasms”

Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
Martha Hering · Westat, Inc.$57,098,843

Research focus

Malignant NeoplasmsCellsLipidsCell GrowthLightHomeostasisMetabolicSignal TransductionBiologicalTissuesBreast Cancer CellBreast Cancer ModelImpairmentIn VivoIn VitroGeneticCancer Cell GrowthGrowthMalignant Breast NeoplasmBreast Cancer PatientBreast TumorigenesisFamilyEventCell Model